Abstract
OBJECTIVE: To measure patient preferences for four different screening strategies: annual fecal occult blood testing (FOBT) alone; flexible sigmoidoscopy (FSIG) every 5 years alone; both annual FOBT and FSIG every 5 years; or no screening.
DESIGN: Survey.
SETTING: University internal medicine clinic.
PATIENTS: Convenience sample of 146 adults (aged 50–75 years) with no previous history of colon cancer.
INTERVENTION: Three-part educational program on colon cancer screening administered verbally by trained research assistants.
MEASUREMENTS AND MAIN RESULTS: Patient preferences for screening were measured at three points: after descriptive information about colon cancer and screening options (testing procedure information); after information about test performance but with no out-of-pocket costs (test performance information); and finally with hypothetical out-of-pocket costs (cost information). After only descriptive test information, the most popular strategies were FOBT alone (45%) or both tests (38%). Fewer patients preferred FSIG alone (13%). After information about test performance, more subjects preferred both tests (47%), and fewer subjects preferred FOBT alone (36%) (p=.12). With hypothetical out-of-pocket costs, the proportion preferring FOBT alone increased to 53%, while those preferring both tests decreased to 31% (p<.001). Less than 5% of patients preferred no screening.
CONCLUSIONS: Patient preferences for colon cancer screening were modestly sensitive to information about test performance and strongly sensitive to out-of-pocket costs. The heterogeneity of patients’ preferences for how to be screened supports informed shared decision making as a possible means of improving colon cancer screening.
Similar content being viewed by others
References
US Preventive Health Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Alexandria, Va: International Medical Publishing; 1996.
Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594–642.
Mandel J, Bond J, Church T, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–71.
Kronborg O, Fenger C, Olsen J, Jorgensen D, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71.
Hardcastle J, Chamberlain J, Robinson M, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.
Selby J, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7.
Centers for Disease Control and Prevention. Screening for colon cancer. MMWR. 1996;45:107–10.
Pignone M, Harris R, Kinsinger L. Changing cancer screening practice: physician or patient activation? J Gen Intern Med. 1997;14(Suppl 1):110.
Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? Soc Sci Med. 1997;44:681–92.
Coulter A, Entwhistle V, Gilbert D. Sharing decisions with patients: is the information good enough? BMJ. 1999;318:318–22.
Greenfield S, Kaplan S, Ware J, Yano E, Frank H. Patients’ participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3:448–57.
Flood A, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. J Gen Intern Med. 1996;11:342–9.
Leard L, Savides T, Ganiats T. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45:211–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pignone, M., Bucholtz, D. & Harris, R. Patient preferences for colon cancer screening. J GEN INTERN MED 14, 432–437 (1999). https://doi.org/10.1046/j.1525-1497.1999.00018.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.1999.00018.x